APOE genotype in cerebrovascular disease and vascular dementia
- 15 November 2002
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 203-204, 173-176
- https://doi.org/10.1016/s0022-510x(02)00286-1
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-ε4 allele in Latin Americans: findings from the Maracaibo Aging StudyNeuroscience Letters, 2001
- Effect of the Apolipoprotein E ε4 Allele on White Matter Hyperintensities in DementiaStroke, 2000
- Impact of Apolipoprotein E ε4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin StudyStroke, 1999
- Prevalence of Apolipoprotein E Alleles in Healthy Subjects and Survivors of Ischemic StrokeStroke, 1998
- Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly MenStroke, 1996
- Apolipoprotein E Polymorphism and Stroke in a Population Sample Aged 75 Years or MoreStroke, 1996
- Relation of Coronary Atherosclerosis and Apolipoprotein E Genotypes in Alzheimer PatientsStroke, 1995
- Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimerʼs diseaseCurrent Opinion in Lipidology, 1995
- Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.Stroke, 1993
- Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.Stroke, 1992